These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Pregabalin abuse after past substance-seeking behavior. Papazisis G; Garyfallos G; Sardeli C; Kouvelas D Int J Clin Pharmacol Ther; 2013 May; 51(5):441-2. PubMed ID: 23547854 [TBL] [Abstract][Full Text] [Related]
45. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia. Montgomery SA; Herman BK; Schweizer E; Mandel FS Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983 [TBL] [Abstract][Full Text] [Related]
46. Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study. Pae CU; Marks DM; Han C; Masand PS; Patkar AA Int Clin Psychopharmacol; 2009 Jan; 24(1):29-33. PubMed ID: 19060720 [TBL] [Abstract][Full Text] [Related]
47. [Pharmacotherapy of anxiety disorders in patients with chronic cerebral ischemia]. Vorob'eva OV; Rusaya VV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12. Vyp. 2):49-55. PubMed ID: 28300804 [TBL] [Abstract][Full Text] [Related]
48. The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery. Gonano C; Latzke D; Sabeti-Aschraf M; Kettner SC; Chiari A; Gustorff B J Psychopharmacol; 2011 Feb; 25(2):249-53. PubMed ID: 19825903 [TBL] [Abstract][Full Text] [Related]
49. Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants. Lotarski SM; Donevan S; El-Kattan A; Osgood S; Poe J; Taylor CP; Offord J J Pharmacol Exp Ther; 2011 Aug; 338(2):615-21. PubMed ID: 21558437 [TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Buoli M; Caldiroli A; Serati M Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):351-359. PubMed ID: 28075650 [TBL] [Abstract][Full Text] [Related]
51. Pregabalin (Lyrica, Pfizer, Inc.). Roman M Issues Ment Health Nurs; 2009 Feb; 30(2):138-9. PubMed ID: 19212874 [No Abstract] [Full Text] [Related]
52. Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety. Micó JA; Prieto R CNS Drugs; 2012 Aug; 26(8):637-48. PubMed ID: 22784017 [TBL] [Abstract][Full Text] [Related]
54. Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions. Fagan HA; Baldwin DS Expert Rev Neurother; 2023 Jun; 23(6):535-548. PubMed ID: 37183813 [TBL] [Abstract][Full Text] [Related]
55. Comments on article by Mitte and associates: "A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder". Magalhães PV J Clin Psychopharmacol; 2006 Apr; 26(2):220-1; author reply 221. PubMed ID: 16633161 [No Abstract] [Full Text] [Related]
56. Statistical alchemy for drug treatment of generalized anxiety disorder: a commentary on the meta-analysis by Baldwin et al. [BMJ 2011;342:d1199]. Fava GA Psychother Psychosom; 2011; 80(5):261-3. PubMed ID: 21654185 [No Abstract] [Full Text] [Related]